These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11086312)

  • 21. The treatment of Kawasaki disease.
    Sagraves R
    J Pediatr Health Care; 1993; 7(6):278-82. PubMed ID: 8106928
    [No Abstract]   [Full Text] [Related]  

  • 22. A cost-benefit analysis of intravenous immunoglobulin treatment in children with Kawasaki disease.
    Arj-ong S; Chotivitayatarakorn P; Lertsapcharoen P; Khongphatthanayothin A; Thisyakorn C
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S179-88. PubMed ID: 12929987
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What do we know about Kawasaki disease?
    Kucińska B; Wróblewska-Kałuzewska M
    Med Sci Monit; 2000; 6(6):1227-31. PubMed ID: 11208484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiology patient pages. Kawasaki disease.
    Baker AL; Newburger JW
    Circulation; 2008 Aug; 118(7):e110-2. PubMed ID: 18695195
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical features of patients with Kawasaki disease whose parents had the same disease.
    Uehara R; Yashiro M; Nakamura Y; Yanagawa H
    Arch Pediatr Adolesc Med; 2004 Dec; 158(12):1166-9. PubMed ID: 15583102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular involvement in Kawasaki disease.
    Narayanan SN; Ahamed MZ; Safia M
    Indian Pediatr; 2005 Sep; 42(9):918-22. PubMed ID: 16208052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistant Kawasaki disease.
    Nachiappan J; May M; Hawker RE; Hong P
    J Paediatr Child Health; 2004; 40(9-10):576-8. PubMed ID: 15367156
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravenous immunoglobulin therapy induces neutrophil apoptosis in Kawasaki disease.
    Tsujimoto H; Takeshita S; Nakatani K; Kawamura Y; Tokutomi T; Sekine I
    Clin Immunol; 2002 May; 103(2):161-8. PubMed ID: 12027421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of immunoglobulin retreatment in Kawasaki disease.
    Falcini F; Ermini M; Trapani S; Taccetti G
    J Pediatr; 1994 Oct; 125(4):672-3. PubMed ID: 7931898
    [No Abstract]   [Full Text] [Related]  

  • 30. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy.
    Yoshida S; Sakurai Y; Takeda T; Fukuda K
    J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975
    [No Abstract]   [Full Text] [Related]  

  • 31. A report of two cases of Kawasaki disease treated with plasma exchange.
    Harada T; Ito S; Shiga K; Inaba A; Machida H; Aihara Y; Yokota S
    Ther Apher Dial; 2008 Apr; 12(2):176-9. PubMed ID: 18387169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease.
    Tacke CE; Smits GP; van der Klis FR; Kuipers IM; Zaaijer HL; Kuijpers TW
    J Allergy Clin Immunol; 2013 Jun; 131(6):1701-3. PubMed ID: 23498596
    [No Abstract]   [Full Text] [Related]  

  • 33. Severe cutaneous manifestations in a child with refractory Kawasaki disease.
    Falcini F; Ricci L; Poggi GM; Simonini G; Calabri GB; de Martino M
    Rheumatology (Oxford); 2006 Nov; 45(11):1444-5. PubMed ID: 16847007
    [No Abstract]   [Full Text] [Related]  

  • 34. Non-classical Kawasaki disease in a 2 month old infant.
    Hartmann I; Weiss K; Bistritzer T; Baram S; Goldman M
    Isr Med Assoc J; 2006 Aug; 8(8):581-2. PubMed ID: 16958253
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gamma globulins and Kawasaki disease].
    Musumeci S; Fischer A; Di Dio R
    Pediatrie; 1986 Jun; 41(4):333-5. PubMed ID: 2433677
    [No Abstract]   [Full Text] [Related]  

  • 36. [Kawasaki syndrome and Mycoplasma pneumoniae infection].
    Merlin E; Al Fatuhi H; Crost P
    Arch Pediatr; 2004 Aug; 11(8):972-3. PubMed ID: 15288092
    [No Abstract]   [Full Text] [Related]  

  • 37. [Kawasaki disease in infants younger than six month of age: report of four cases].
    Zhao W; Li F; Chen LJ; Dai K
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):401-3. PubMed ID: 19470268
    [No Abstract]   [Full Text] [Related]  

  • 38. Adult Kawasaki disease: evaluating the fluctuation of circulating lymphocytes associated with i.v. immunoglobulin treatment.
    Fujimoto N; Teramura K; Tanaka T
    J Dermatol; 2012 Nov; 39(11):957-8. PubMed ID: 22390144
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of immunoglobulin in the prevention of coronary artery aneurysms in Kawasaki disease].
    Chaker L; Drissa MA; Drissa H
    Tunis Med; 2009 Mar; 87(3):228-9. PubMed ID: 19537024
    [No Abstract]   [Full Text] [Related]  

  • 40. Kawasaki disease.
    Huang TY
    Acta Paediatr Taiwan; 2004; 45(1):6-7. PubMed ID: 15264698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.